Trichosanthin has potent inhibiting activity of protein synthesis in a cell-free system and its antibody-conjugate exhibits potentiated cytotoxicity to tumor cells in vitro
Wang, Q.C.; Zhang, Z.F.; Wang, J.; Xie, H.; Yang, Z.H.
Shi Yan Sheng Wu Xue Bao 20(4): 515-519
1987
ISSN/ISBN: 0001-5334
PMID: 2834902
Accession: 041866118
PDF emailed within 1 workday: $29.90
Related References
Yu, S.; Zhang, J.; Yan, Y.; Yao, X.; Fang, L.; Xiong, H.; Liu, Y.; Chu, Q.; Zhou, P.; Wu, K. 2019: A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells Journal of Experimental and Clinical Cancer Research: Cr 38(1): 355Munekage, E.; Serada, S.; Tsujii, S.; Yokota, K.; Kiuchi, K.; Tominaga, K.; Fujimoto, M.; Kanda, M.; Uemura, S.; Namikawa, T.; Nomura, T.; Murakami, I.; Hanazaki, K.; Naka, T. 2021: A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma Neoplasia 23(9): 939-950
Wang, Q.C.; Ying, W.B.; Xie, H.; Zhang, Z.C.; Yang, Z.H.; Ling, L.Q. 1991: Trichosanthin-monoclonal antibody conjugate specifically cytotoxic to human hepatoma cells in vitro Cancer Research 51(13): 3353-3355
Baxter, C.S.; Fish, L.A.; Ferguson, T.A.; Michael, J.G.; Bash, J.A. 1982: Effects of tumor-promoting agents on cells of the murine immune system: inhibition of antibody synthesis and of macrophage-mediated tumor cell cytotoxicity Carcinogenesis; A Comprehensive Survey 7: 637-642
Wang, R.; Lai, Q.; Tang, L.; Tao, Y.; Yao, Y.; Liu, Y.; Lu, Y.; Shen, C.; Lu, R.; Fan, C.; Zhang, R.; Wang, Y.; Yu, L.; Yang, T.; Wu, Y.; Peng, Y.; Wei, X.; Fu, Y.; Lai, W.; Gou, L.; Yang, J. 2018: A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models American Journal of Cancer Research 8(4): 610-623
Kovtun, Y.; Noordhuis, P.; Whiteman, K.R.; Watkins, K.; Jones, G.E.; Harvey, L.; Lai, K.C.; Portwood, S.; Adams, S.; Sloss, C.M.; Schuurhuis, G.J.; Ossenkoppele, G.; Wang, E.S.; Pinkas, J. 2018: IMGN779, a Novel CD33-Targeting Antibody-Drug Conjugate with DNA-Alkylating Activity, Exhibits Potent Antitumor Activity in Models of AML Molecular Cancer Therapeutics 17(6): 1271-1279
Lin, B.; Yang, X.-Z.; Cao, X.-W.; Zhang, T.-Z.; Wang, F.-J.; Zhao, J. 2017: A novel trichosanthin fusion protein with increased cytotoxicity to tumor cells Biotechnology Letters 39(1): 71-78
Huhe, M.; Lou, J.; Zhu, Y.; Zhao, Y.; Shi, Y.; Wang, B.; Sun, X.; Zhang, X.; Zhang, Y.; Chen, Z.-N. 2019: A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer Biochemical and Biophysical Research Communications 513(4): 1083-1091
Iwamaru, Y.; Miyake, M.; Arii, J.; Tanabe, Y.; Noda, M. 2001: An inhibitory factor for cell-free protein synthesis from Salmonella enteritidis exhibits cytopathic activity against Chinese hamster ovary cells Microbial Pathogenesis 31(6): 283-293
Breij, E.C.W.; de Goeij, B.E.C.G.; Verploegen, S.; Schuurhuis, D.H.; Amirkhosravi, A.; Francis, J.; Miller, V.B.; Houtkamp, M.; Bleeker, W.K.; Satijn, D.; Parren, P.W.H.I. 2014: An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors Cancer Research 74(4): 1214-1226
Ab, O.; Whiteman, K.R.; Bartle, L.M.; Sun, X.; Singh, R.; Tavares, D.; LaBelle, A.; Payne, G.; Lutz, R.J.; Pinkas, J.; Goldmacher, V.S.; Chittenden, T.; Lambert, J.M. 2015: IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors Molecular Cancer Therapeutics 14(7): 1605-1613
Wang, F.; Zhang, X.; Li, S. 1995: Internalization of antigastric cancer antibody-trichosanthin conjugate and impact of ras oncogene expression on the conjugate-induced apoptosis in the target cells Zhonghua Weishengquxue He Mianyixue Zazhi 15(2): 131-134
Yan, W.; Wu, T.H.Y.; Leung, S.S.Y.; To, K.K.W. 2020: Flavonoids potentiated anticancer activity of cisplatin in non-small cell lung cancer cells in vitro by inhibiting histone deacetylases Life Sciences 258: 118211
Chen, T.C.; Cho, H.-Y.; Wang, W.; Barath, M.; Sharma, N.; Hofman, F.M.; Schönthal, A.H. 2014: A novel temozolomide-perillyl alcohol conjugate exhibits superior activity against breast cancer cells in vitro and intracranial triple-negative tumor growth in vivo Molecular Cancer Therapeutics 13(5): 1181-1193
Tonevitskiĭ, A.G.; Zhukova, O.S.; Rakhmanova, V.A.; Arsen'eva, E.L.; Bogacheva, G.T. 1988: Selective cytotoxicity of antibody-ricin-A-chain conjugate for human tumor B cells. II. Comparison of activity of immunotoxins conjugated with poly- and monoclonal antibodies Molekuliarnaia Biologiia 22(4): 911-916
Eisenthal, A.; Rosenberg, S.A. 1989: The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha Journal of Immunology 142(7): 2307-2313
Isoai, A.; Goto-Tsukamoto, H.; Murakami, K.; Akedo, H.; Kumagai, H. 1993: A potent anti-metastatic activity of tumor invasion-inhibiting factor-2 and albumin conjugate Biochemical and Biophysical Research Communications 192(1): 7-14
Smith, L.M.; Nesterova, A.; Alley, S.C.; Torgov, M.Y.; Carter, P.J. 2006: Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97 Molecular Cancer Therapeutics 5(6): 1474-1482
Abdollahpour-Alitappeh, M.; Lotfinia, M.; Bagheri, N.; Sineh Sepehr, K.; Habibi-Anbouhi, M.; Kobarfard, F.; Balalaie, S.; Foroumadi, A.; Abbaszadeh-Goudarzi, G.; Abbaszadeh-Goudarzi, K.; Abolhassani, M. 2019: Trastuzumab-monomethyl auristatin e conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer Journal of Cellular Physiology 234(3): 2693-2704
Lee, H.; Lee, H.; Kwon, Y.; Lee, J.-H.; Kim, J.; Shin, M.-K.; Kim, S.-H.; Bae, H. 2010: Methyl gallate exhibits potent antitumor activities by inhibiting tumor infiltration of CD4+CD25+ regulatory T cells Journal of Immunology 185(11): 6698-6705